Add BrightSurf on Google Email

Personalized support program improves smoking cessation for cervical cancer survivors

A new study by UCLA researchers shows that a personalized counseling program, called Motivation and Problem-Solving (MAPS), can help cervical cancer survivors quit smoking, with twice as many women quitting compared to standard support. The program's cost-effectiveness is also demonstrated, with the probability of being cost-effective ...

How bacteria may promote breast cancer

Pathogenic bacteria in gut and breast tissue can promote breast cancer development by increasing SMOX activity, leading to DNA damage and tumor growth. Targeting SMOX with inhibitors could be a viable strategy to counteract the cancer-promoting effects of microbial dysbiosis.

SourceJohns Hopkins Medicine·JournalCancer Research·DateFeb 16, 2026

Clostridioides difficile: A suspected pro-carcinogenic bacterium for gastrointestinal tumors

A recent review suggests that Clostridioides difficile infection may promote the development of gastrointestinal tumors, including colorectal cancer. The bacterium's toxins can cause damage to the epithelial cytoskeleton and induce inflammation, leading to chronic colitis and increased risk of CRC.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalChinese Medical Journal·TypeLiterature review·DateDec 22, 2025

Potentially toxic elements in bananas grown in the Mariana disaster region exceed FAO limits

The study found that consuming bananas grown in soil impacted by iron mining waste poses a possible health risk to children aged six years or younger. The team correlated the risk to human health with the transfer of toxic elements from the soil to the plant, revealing high concentrations of cadmium, chromium, and other metals.

SourceFundação de Amparo à Pesquisa do Estado de São Paulo·JournalEnvironmental Geochemistry and Health·DateDec 19, 2025

Blood test may help identify which colon cancer patients benefit from NSAIDs

A blood test may help doctors identify which patients with colon cancer can benefit from anti-inflammatory medication and chemotherapy after surgery. The test measures circulating tumor DNA levels, and high-risk patients who test positive see improved survival rates when taking celecoxib with chemotherapy.

SourceAlliance for Clinical Trials in Oncology·JournalJAMA Oncology·TypeRandomized controlled/clinical trial·DateDec 15, 2025

Cell-free DNA Could Detect Adverse Events from Immunotherapy

Researchers developed a non-invasive blood test to detect genetic material shed by tumors, which can identify adverse events related to immune checkpoint inhibitor therapy. The test found evidence of multi-organ injury in patients with immune-related adverse events, suggesting that the clinical syndromes may represent only a small frac...

SourceJohns Hopkins Medicine·JournalNew England Journal of Medicine·DateDec 10, 2025

GLP-1 receptor agonists likely have little or no effect on obesity-related cancer risk

A systematic review and meta-analysis found that GLP-1 receptor agonists probably have little or no effect on the risk of thyroid, pancreatic, breast, or kidney cancer in patients with type 2 diabetes or overweight/obesity. However, longer-term studies are needed to clarify potential risks or benefits for other obesity-related cancers.

SourceAmerican College of Physicians·JournalAnnals of Internal Medicine·TypeNews article·DateDec 8, 2025

Chinese Neurosurgical Journal study explores AI tool to predict medulloblastoma subtypes and genetic risks with high accuracy

A new study published in the Chinese Neurosurgical Journal explores an AI tool that identifies medulloblastoma subgroups based on magnetic resonance imaging scans. The model achieved impressive accuracy in predicting molecular subtypes and genetic risk factors, with 91% accuracy for TP53 mutations and 87% accuracy for chromosome 11 loss.

SourceChinese Neurosurgical Journal·JournalChinese Neurosurgical Journal·TypeImaging analysis·DateNov 5, 2025

New USC study identifies key genes linked to aggressive prostate cancer in people of African descent

A new USC study identified five genes linked to aggressive prostate cancer in people of African descent, including ATM, BRCA2, CHEK2, HOXB13 and PALB2. The researchers developed a method combining genetic risk scores with family history and specific variant presence for personalized monitoring and treatment strategies.

SourceKeck School of Medicine of USC·JournalEuropean Urology·TypeMeta-analysis·DateNov 5, 2025

Smoking and biological sex shape healthy bladder tissue evolution, offering clues to cancer risk

Researchers found that smoking and biological sex shape how normal cells evolve in healthy bladder tissue, with certain mutations gaining an advantage to expand into clones. This study offers new insights into cancer risk and prevention by providing a way to understand tissue evolution and identify early warning signs.

SourceInstitute for Research in Biomedicine (IRB Barcelona)·JournalNature·TypeComputational simulation/modeling·DateOct 8, 2025

AI and the Future of Cancer Research and Cancer Care to headline October 24 gathering of global oncology leaders at the National Press Club: NFCR Global Summit to feature top scientists, entrepreneurs, and cancer-care innovators

The 2025 NFCR Global Summit will convene world-renowned experts in cancer research, entrepreneurship, and patient care. Keynote speakers include Monica Bertagnolli, Webster K. Cavenee, Lisa Coussens, Ronald DePinho, and Tony Hunter.

Research reveals a new prognostic factor for advanced lung adenocarcinoma

A new study in The American Journal of Pathology reveals that perilipin 2 protein modulates aggressive cancer progression in advanced lung adenocarcinoma by regulating lipid droplet accumulation. High perilipin 2 expression is associated with more aggressive disease progression and shorter recurrence-free survival times.

SourceElsevier·JournalAmerican Journal Of Pathology·TypeExperimental study·DateAug 5, 2025

Research alert: Cannabis use disorder triples risk of oral cancer

A recent study by researchers at University of California San Diego School found that individuals with cannabis use disorder are more than three times more likely to develop oral cancer within five years. The study highlights the potential long-term health risks associated with problematic cannabis use and emphasizes the need for furth...

SourceUniversity of California - San Diego·JournalPreventive Medicine Reports·DateJul 29, 2025